Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Van Den Mooter

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 6, 2019
Empagliflozin in type 1 diabetesChantal Mathieu, Laura Van Den Mooter, Bert Eeckhout
Expert Opinion on Pharmacotherapy|March 15, 2018
Efficacy of dapagliflozin as an adjunct therapy in patients with inadequately controlled type 1 diabetes mellitusLaura Van den Mooter, Simon Caerels, Chantal Mathieu
Nature Communications|April 14, 2015
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell stateAnnelien Verfaillie, Hana Imrichova, Zeynep Kalender Atak, et al.
Science (New York, N.Y.)|November 23, 2019
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in miceIván M Moya, Stéphanie A Castaldo, Laura Van den Mooter, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|November 6, 2019
Empagliflozin in type 1 diabetesChantal Mathieu, Laura Van Den Mooter, Bert Eeckhout
Expert Opinion on Pharmacotherapy|March 15, 2018
Efficacy of dapagliflozin as an adjunct therapy in patients with inadequately controlled type 1 diabetes mellitusLaura Van den Mooter, Simon Caerels, Chantal Mathieu
Nature Communications|April 14, 2015
Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell stateAnnelien Verfaillie, Hana Imrichova, Zeynep Kalender Atak, et al.
Science (New York, N.Y.)|November 23, 2019
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in miceIván M Moya, Stéphanie A Castaldo, Laura Van den Mooter, et al.
Pageof 1